NCT06278532Recruiting
Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS
Validation of the Lithuanian Version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and the Schizophrenia Cognition Rating Scale
Source: ClinicalTrials.gov · Last updated 26 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to validate the Lithuanian version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale in a Lithuanian sample. This will be done by comparing results obtained from the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale with results obtained from the Positive and Negative Symptoms Scale, the Montgomery Asberg Depression Rating Scale, and the Montreal Cognitive Assessment test.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 16 Jan 2024
- Start date
- 11 Dec 2023
- Primary completion date
- 11 Dec 2026
- Lead sponsor
- Lithuanian University of Health Sciences
- Diseases
- Schizophrenia
- NCT number
- NCT06278532
What you commit to
- Study type: Observational
- Planned participants: 200
- From 11 Dec 2023 to the primary completion date, 11 Dec 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with a comorbid or primary diagnosis of mental and behavioural disorders due to psychoactive substance use (F10 - F19)
- Patients with a comorbid of primary diagnosis of organic, including symptomatic, mental disorders (F00 - F09)
Age
- Age younger than 18 or older than 65 years old;
Other
- Did not sign the informed consent form;
- Legally inactive person
- Patients with a comorbid or primary diagnosis of mental retardation according to ICD-10 (F70 - F79);
Who the study is looking for
- age 18 - 65 years old;
- Diagnosis of F20, F25 or F21 according to ICD-10;
- Signed informed consent form.
Age in the registry: 18 years to 65 years · Sex: All
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Lithuanian University of Health Sciences Hospital Kaunas Clinics Coordinator of this site? Confirm its status | Kaunas | Lithuania | Recruiting |
| Jonas Montvidas Coordinator of this site? Confirm its status | Kaunas | Lithuania | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.